Alex Zapesochny
CEO @ Clerio Vision
Rochester, United States
Alex Zapesochny is a Series A investor at Clerio Vision in Rochester focused on Medical and Health Care. Alex Zapesochny is the CEO at Clerio Vision. He attended University of Cambridge.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Alex Zapesochny invests in
Stages Alex Zapesochny invests in
Countries Alex Zapesochny invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
Stage
- Series A 1 (50%)
- Series D 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Clerio Vision
|
Clerio Vision is a medical device company that specializes in the fields of refractive, laser, ophthalmic, medical device, contact lenses, and intraocular lenses. The company is in process of developing and commercializing a portfolio of next-generation products in contact lenses.Clerio Vision was founded in 2014 and headquartered in Rochester,New York. | $11.9M / Series D / Jul 10, 2019 | |
|
Clerio Vision
|
Clerio Vision is a medical device company that specializes in the fields of refractive, laser, ophthalmic, medical device, contact lenses, and intraocular lenses. The company is in process of developing and commercializing a portfolio of next-generation products in contact lenses.Clerio Vision was founded in 2014 and headquartered in Rochester,New York. | $3.7M / Series A / Jan 13, 2015 |
Co-Investors
About Clerio Vision
Clerio Vision is a medical device company that specializes in the fields of refractive, laser, ophthalmic, medical device, contact lenses, and intraocular lenses. The company is in process of developing and commercializing a portfolio of next-generation products in contact lenses.Clerio Vision was founded in 2014 and headquartered in Rochester,New York.
Clerio Vision Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexandra Latypova
Co-Founder, Executive vice President and Director
|
|||
|
Alex Zapesochny
CEO
|
|||
Jay B. Baker
CFO
|
|||
J. Mikael Totterman
Founder & Chief Innovation Officer
|
|||
Trevor McCaw
President and CCO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Alex Zapesochny invest in?
Alex Zapesochny invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series D stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alex Zapesochny?
Public channels for Alex Zapesochny include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alex Zapesochny last invest?
The most recent investment recorded for Alex Zapesochny closed in Jul 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
